{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20296", "batch_size": 200, "batch_pos": 86, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "'plans to launch' and 'could respond very quickly' are neutral phrases. No high-potency language is present.", "method": "llm_batch", "batch_id": "batch_2_9072", "batch_size": 200, "batch_pos": 54, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_18352", "batch_size": 200, "batch_pos": 177, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17940", "batch_size": 200, "batch_pos": 166, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "Reports historical fact but lacks explicit calming language or keywords.", "method": "llm_batch", "batch_id": "batch_5_13928", "batch_size": 200, "batch_pos": 163, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_5684", "batch_size": 200, "batch_pos": 123, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment states a historical fact, not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_12364", "batch_size": 200, "batch_pos": 99, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "no", "rationale": "States a historical fact about research, not a current capability or preparedness measure.", "method": "llm_batch", "batch_id": "batch_8_16928", "batch_size": 200, "batch_pos": 115, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 9, "answer": "no", "rationale": "The segment reports history, not reporting prices, economic data, or numerical metrics.", "method": "llm_batch", "batch_id": "batch_9_14784", "batch_size": 200, "batch_pos": 145, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 10, "answer": "no", "rationale": "The segment does not speculate about potential future relief or improvement.", "method": "llm_batch", "batch_id": "batch_10_16320", "batch_size": 200, "batch_pos": 86, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 11, "answer": "no", "rationale": "No direct quote from a named or institutional source.", "method": "llm_batch", "batch_id": "batch_11_20456", "batch_size": 200, "batch_pos": 70, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 12, "answer": "yes", "rationale": "Factual report of research history without explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_19536", "batch_size": 200, "batch_pos": 70, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
